Remove Cosmetics Remove Marketing Remove Regulation
article thumbnail

Conference Notebook: ACI’s Cosmetics and Personal Care Products Conference

FDA Law Blog

As readers of our blog know, MoCRA was a significant change to regulation of cosmetics. Now in the second year of implementation, companies have started noticing the consequences as FDA implements the new requirements and develops regulations and guidance.

article thumbnail

Doctoring the Law: Congress May Let FDA Regulate the Practice of Medicine

FDA Law Blog

FDA , which held that that banning a single intended use of a specific device was inconsistent with the Federal Food, Drug, and Cosmetic Act’s (“FDC Act”) clear pronouncement that FDA cannot regulate the practice of medicine. This provision represents a complete shift in the way FDA is allowed to regulate products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CBD Research: A Dive into the Regulations of Cannabis Research

Advarra

Even though CBD and cannabis usage has grown, and marketing claims have proliferated regarding potential therapeutic applications, there is still little research on their effects on the human body. The post CBD Research: A Dive into the Regulations of Cannabis Research appeared first on Advarra. Funding Research on Cannabis.

article thumbnail

The Art and Science of Panelist Recruitment for Cosmetics Clinical Studies

Cloudbyz

In the cosmetics industry, innovation is key to staying ahead of the competition. As consumer preferences evolve and regulatory demands increase, cosmetics companies are under pressure to prove the safety and efficacy of their products through rigorous clinical studies.

article thumbnail

In the News: August 2021 Regulatory and Development Updates

Camargo

devices must be regulated as devices, and drugs—if they do not also satisfy the device definition—must be regulated as drugs.”. PANDAs have historically been overseen by the FDA’s Office of Generic Drugs and thus regulated more like a generic than an NDA. Final Regulation Issued for “Intended Use”.

article thumbnail

Building Consumer Trust: How Cloudbyz Safety Solution Transforms Safety Vigilance in Cosmetics

Cloudbyz

The cosmetics and personal care industry is one where customer trust is paramount, given that the products are applied directly to the skin, hair, and body. These solutions are designed to monitor, detect, evaluate, and prevent any adverse effects associated with the use of a product after it has been released on the market.

article thumbnail

FDA Designations for Rare Disease Products, Part 1

Camargo

Where is the regulation found? 21 Code of Federal Regulations (CFR) §316 ; Orphan Drug Act. Section 529 of the Federal Food, Drug, and Cosmetic Act (FD&C Act)/ 21 United States Code (USC) §360ff. Additional criteria for the marketing application must be met to obtain the benefits. • Orphan Drug Designation.